As of June 2024 Matinas BioPharma has a market cap of $38.95 Million. This makes Matinas BioPharma the world's 7940th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $38.95 M | -17.08% |
2023 | $46.97 M | -56.68% |
2022 | $0.10 B | -50.35% |
2021 | $0.21 B | -19.56% |
2020 | $0.27 B | -26.69% |
2019 | $0.37 B | 449.45% |
2018 | $67.4 M | -37.48% |
2017 | $0.10 B | 32.68% |
2016 | $81.26 M | 67.21% |
2015 | $48.6 M | 234.46% |
2014 | $14.53 M |
On Jun 25th, 2024 the market cap of Matinas BioPharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.45 B | 1,066.64% | ๐บ๐ธ USA |